Two Directors at Dr. Lal PathLabs Ltd sold after exercising options/sold 2,500 shares at between 2,234.800INR and 2,300.000INR. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades ...
A director at IOI Properties Group Berhad sold 5,600,000 shares at 2.297MYR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Crédit Agricole Normandie Seine : Descriptif du programme de rachat des CCI CAISSE REGIONALE DE CREDIT AGRICOLE MUTUEL DE NORMANDIE-SEINE Société coopérative à capital et personnel variables Siège social : Cité de l’Agriculture Chemin de la Bretèque 76230 BOIS GUILLAUME Siret 433 786 738 000 16 - APE 651 D Société de courtage d’assurance immatriculée auprès de l’ORIAS sous le numéro 07 025 320. Titulaire de la carte professionnelle Transaction, Gestion immobilière et syndic numéro CPI 7606 2020 000 045 179 délivrée par la CCI de Rouen, bénéficiant de la Garantie financièr...
Moody's Ratings (Moody's) has today affirmed Devoteam Group SAS's (Devoteam or the company) B2 corporate family rating (CFR) and B2-PD probability of default rating (PDR). Concurrently, Moody's has affirmed the B2 rating on Devoteam's outstanding €565 million senior secured term loan B, and €100 mil...
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 HOUSTON, TEXAS, March 29, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and ...
Tri Pointe Homes, Inc. Announces First Quarter 2024 Earnings Release and Conference Call Date INCLINE VILLAGE, Nev., March 29, 2024 (GLOBE NEWSWIRE) -- Tri Pointe Homes, Inc. (NYSE: TPH) announced today that it will release its financial results for the first quarter of 2024 before the market opens on Thursday, April 25, 2024. The Company will host a conference call on the same day to discuss the results at 7:00 AM Pacific (10:00 AM Eastern). The call will be hosted by Doug Bauer, Chief Executive Officer, Tom Mitchell, Chief Operating Officer, Glenn Keeler, Chief Financial Officer, and Li...
LECTRA: Availability of 2023 Annual Financial Report Lectra: Availability of 2023 Annual Financial Report Paris, March 29, 2024 - Lectra announces that its 2023 Annual Financial Report has been released and filed with the French Financial Markets Authority (Autorité des marchés financiers). The 2023 Annual Financial Report containing the Management Report, the Report on Corporate Governance and Non-financial Statement is now available in the ESEF format (European Single Electronic Format) and in PDF version on the company’s website: . A condensed English version of the Annual Financial R...
LECTRA : mise à disposition du Rapport financier annuel 2023 Lectra : mise à disposition du Rapport financier annuel 2023 Paris, le 29 mars 2024 - Lectra annonce avoir mis à disposition du public et déposé auprès de l'Autorité des marchés financiers son Rapport financier annuel 2023. Le Rapport financier annuel 2023 contenant le Rapport de gestion, le Rapport sur le gouvernement d’entreprise et la Déclaration de performance extra-financière peut être consulté au format ESEF (European Single Electronic Format) et en version PDF sur le site Internet de la Société : . Une version co...
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 29, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced the appointment of Dr. Archie Tse as Head of Research & Development, reporting to Mr. Carsten Lu, CEO and Chairman of Adlai Nortye, effective March 29th, 2024. Dr. Tse, M.D. & Ph.D. earned Doctor of Medicine and Doctor of Biochemi...
PSA Today Japan Market Comment by Pelham Smithers, Julie Boote, Joel Scheiman, William Nestuk, Lindsay Whipp and Hiroyuki Terada Tags: M3 Inc (2413 JT), Fanuc (6954 JT), MHI (7011 JT), KHI (7012 JT), IHI (7013 JT), Kokusai Electric (6525 JT), Advantest (6857 JT), Disco (6146 JT), Nvidia (NVDA US), Lasertec (6920 JT), Nintendo (7974 JT), Sega Sammy (6460 JT), Capcom (9697 JT), Fujitsu (6702 JT), Toyota Motor (7203 JT), Yonetani Die & Mold (pvt), Koiwai Co (pvt), General Motors (GM US), Tooling &...
A director at Kinergy Advancement Berhad bought 9,553,900 shares at 0.364MYR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
PARIS--(BUSINESS WIRE)-- Regulatory News: Conformément à l’article 5 du Règlement européen n° 596/2014 (Règlement MAR – Market Abuse Regulation), les informations détaillées sont disponibles sur le site de Tikehau Capital (Paris:TKO) : Déclaration des transactions sur actions propres réalisées du 22 mars 2024 au 28 mars 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondéré moyen journalier d'acquisition ...
A director at Brookfield Asset Management Ltd bought 80,000 shares at 56.540CAD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Baltic Horizon Fund consolidated audited results for 2023 Management Board of Northern Horizon Capital AS has approved the audited financial results of Baltic Horizon Fund (the Fund) for the year 2023. The financial results remained unchanged compared to the preliminary disclosure on 15 February 2024. Executing our strategy In a challenging economic landscape characterized by inflation, interest rate volatility, and recent geopolitical events, the Fund has assessed various strategic options to navigate these complexities and ensure future growth. Over the past year, our focus has been o...
Baltic Horizon Fund consolidated audited results for 2023 Management Board of Northern Horizon Capital AS has approved the audited financial results of Baltic Horizon Fund (the Fund) for the year 2023. The financial results remained unchanged compared to the preliminary disclosure on 15 February 2024. Executing our strategy In a challenging economic landscape characterized by inflation, interest rate volatility, and recent geopolitical events, the Fund has assessed various strategic options to navigate these complexities and ensure future growth. Over the past year, our focus ha...
A director at Celltrion Inc sold 4,328 shares at 184,000.000KRW and the significance rating of the trade was 94/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.